Loading color scheme

News

Virtici Announces Funding to Provide Seed Grants to Exceptional Early-Stage Biomedical Innovations

Virtici, LLC announced today the award of supplemental funds to the ASCEND Accelerator Hub. The ASCEND Accelerator Hub is an NIH-funded consortium led by Virtici and includes 10 of the leading research institutions in the Western States (Alaska, Hawaii, Idaho, Montana, Nevada, New Mexico, and Wyoming).

Read more

Rise Therapeutics awarded $2 Million to Develop a Novel, Immunological-Directed Microbiome-based Medicine for Treatment of Sjögren’s Syndrome

Rockville, MD. Rise Therapeutics announced today it was awarded a $2 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Dental and Craniofacial Research (NIDCR). Grant funds will be used to develop a novel, immunologically enhanced probiotic-based therapeutic for the treatment of Sjögren’s syndrome (SS).

Read more

Monon Bioventures and Purdue University awarded grant to improve diabetes treatment

Diabetes is a disease of high blood sugar. Diabetic patients also can experience extremely low blood sugar, or hypoglycemia, after fasting, exercising or too large a dose of insulin. If untreated, severe hypoglycemia can lead to coma or even death.

Read more

Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Phase II SBIR Grant

Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced that they are a recipient of a Phase II SBIR grant from the National Institutes of Health (NIH) for $2.3 million.

Read more

Virtici-led ASCEND Accelerator Hub Launches New Website for Biomedical Entrepreneurs

Virtici, LLC today announced the launch of an online resource database for biomedical entrepreneurs: http://bioentrepreneurresources.com. This database was developed in collaboration with the DRIVEN Accelerator Hub, a parallel NIH-funded consortium led by Celdara Medical including 10 of the leading research institutions in the Northeast region (NH, VT, ME, DE, and RI).

Read more

Virtici Receives $3.5 Million Accelerator Hub Award from the National Institutes of Health

Virtici announced today that it has received a three-year, $3.5 million award from the National Institutes of Health (NIH) to support an Institutional Development Award (IDeA) Center of Biomedical Research Excellence.

Read more